NIST only participates in the February and August reviews.
NIST has led the Genome in a Bottle Consortium to develop widely-used benchmark germline variant calls for seven human cell lines [1]. Similar extensively characterized benchmark cell lines and DNA are needed to benchmark somatic variant detection in tumors. This project would involve working with a unique group of technology and informatics developers in the public-private-academic Genome in a Bottle Consortium to develop methods to integrate short-, linked-, and long-read sequencing technologies to form benchmarks for somatic variant calls. It will also be important to develop appropriate performance metrics and tools to calculate these metrics for somatic variants, similar to those NIST and the Global Alliance for Genomics and Health developed for germline variants [2].
[1] JM Zook, et al. An open resource for accurately benchmarking small variant and reference calls. Nature Biotechnology 2019, 37, 561.
[2] P Krusche, et al, JM Zook. Best practices for benchmarking germline small-variant calls in human genomes. Nature Biotechnology 2019, 37, 555.
Genomics; Bioinformatics; DNA sequencing; De novo assembly; Machine learning; Reference materials; Precision medicine; Data science; Artificial intelligence
Similar Positions
-
Research Scientist/Engineer: Traceable Nanostructure Measurements, NIST Nanostructure Fabrication and Measurement Group, United States, 3 days ago
Traceable nanostructure measurements to make AI reliable for quantum and semiconductor manufacturing The Nanostructure Fabrication and Measurement Group in the Microsystems and Nanotechnology Divi...
-
Fda Statistical Evaluation Of Td50 And Benchmark Dose Approaches For Carcinogenic Impurities Acceptable Intakes, Center for Drug Evaluation and Research (CDER), United States, about 8 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available in the Office of Immunology and Inflammation (OII), Office of New Drugs (OND), Cente...
-
Fda Utilizing Artificial Intelligence To Enhance Rare Disease Research, Center for Drug Evaluation and Research (CDER), United States, about 8 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately with the Food and Drug Administration (FDA), in The Center for Drug Eval...
-
Fda Development Of A General Surgery Devices Database And Analysis To Identify Key Technological Attributes And Trends, Center for Devices and Radiological Health (CDRH), United States, about 8 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately with the Food and Drug Administration (FDA), Center for Devices and Radi...
-
Fda Dose Optimization Over The Drug Lifecycle, Center for Drug Evaluation and Research (CDER), United States, about 8 hours ago
*Applications will be reviewed on a rolling-basis. FDA Office and Location: A research opportunity is available immediately with the Food and Drug Administration (FDA), Center for Drug Evaluation ...
-
Assistant Clinical Investigator, National Institute of Allergy and Infectious Diseases, NIH, United States, 3 days ago
Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Assistant Clinical Investigators Transition Program in Clinical Research...